Literature DB >> 17593467

No evidence for plasminogen activator inhibitor 1 4G/4G genotype as risk factor for cerebral venous thrombosis.

Christoph Lichy, Manja Kloss, Peter Reismann, Just Genius, Armin Grau, Karl Reuner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17593467     DOI： 10.1007/s00415-006-0417-3

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems.

Authors:  Christoph Lichy; Tuan Dong-Si; Karl Reuner; Just Genius; Henning Rickmann; Toni Hampe; Tarah Dolan; Felix Stoll; Armin Grau
Journal:  J Neurol       Date:  2005-09-16       Impact factor: 4.849

2.  4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.

Authors:  M T Sartori; B Wiman; S Vettore; F Dazzi; A Girolami; G M Patrassi
Journal:  Thromb Haemost       Date:  1998-12       Impact factor: 5.249

3.  Plasminogen activator inhibitor-1 4G/4G-genotype is associated with cerebral sinus thrombosis in factor V Leiden carriers.

Authors:  R Junker; D G Nabavi; E Wolff; P Lüdemann; U Nowak-Göttl; M Käse; R Bäumer; E B Ringelstein; G Assmann
Journal:  Thromb Haemost       Date:  1998-10       Impact factor: 5.249

4.  An alternative method for PAI-1 promoter polymorphism (4G/5G) typing.

Authors:  M Margaglione; E Grandone; G Cappucci; D Colaizzo; N Giuliani; G Vecchione; M d'Addedda; G Di Minno
Journal:  Thromb Haemost       Date:  1997-03       Impact factor: 5.249

5.  Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.

Authors:  P M Ridker; C H Hennekens; K Lindpaintner; M J Stampfer; J P Miletich
Journal:  Circulation       Date:  1997-01-07       Impact factor: 29.690

6.  Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts.

Authors:  Per-Gunnar Wiklund; Lennart Nilsson; Sofie Nilsson Ardnor; Per Eriksson; Lars Johansson; Birgitta Stegmayr; Anders Hamsten; Dan Holmberg; Kjell Asplund
Journal:  Stroke       Date:  2005-07-14       Impact factor: 7.914
  6 in total
  3 in total

1.  Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: a case-control study in adults.

Authors:  Marius Ringelstein; Alexander Jung; Klaus Berger; Monika Stoll; Katharina Madlener; Christof Klötzsch; Felix Schlachetzki; Erwin Stolz
Journal:  J Neurol       Date:  2012-04-12       Impact factor: 4.849

2.  Rivaroxaban attenuates thrombosis by targeting the NF-κB signaling pathway in a rat model of deep venous thrombus.

Authors:  Junhao Ma; Xinxi Li; Yang Wang; Zhenwei Yang; Jun Luo
Journal:  Int J Mol Med       Date:  2017-09-29       Impact factor: 4.101

3.  Prevalence and geographical variation of Factor V Leiden in patients with cerebral venous thrombosis: A meta-analysis.

Authors:  Xinyuan Li; Li Cui; Yunbo Li; Lijun Zhu; Chenglin Wang; Jing Liu; Shaokuan Fang
Journal:  PLoS One       Date:  2018-08-29       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.